Answers are grounded in this paper and cite their sources.
β-U10 (2-naphthyl-U-47700), a novel synthetic opioid (NSO) with potent mu receptor agonist activity, was detected as an adulterant in illicit heroin in Melbourne, Australia in September 2020. Adulteration can counteract low-purity supply, however it poses additional risks of drug-related toxicity. β-U10 was first detected in discarded drug paraphernalia during a pilot study of an early warning system for illicit drug use and in cases from the Emerging Drug Network of Australia VIC (EDNAV) study, which monitors illicit drug use in major hospital emergency department presentations suffering drug-related harm in Victoria. β-U10 was subsequently monitored in coronial cases admitted to the Victorian Institute of Forensic Medicine (VIFM), however due to unavailability of a suitable reference standard contemporary confirmation was not possible. This study evaluates β-U10 prevalence in 211 heroin-related deaths admitted to the VIFM between September 2020 to June 2022. β-U10 was detected in 11 cases, with 64% male and the mean age 44 years. Concentrations ranged from 0.03–40 ng/mL and methylamphetamine and pharmaceutical and novel benzodiazepines commonly co-detected. Nine deaths were caused by drug toxicity, and two attributed to drug toxicity in the setting of significant co-morbidities. It is imperative toxicology services remain vigilant to inform against opioid-related harm.
No takes yet. Share an insight, caveat, or question.
Scully et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: